Medicines Authority Logo
Medicines Authority

Awtorità dwar il-Mediċini



 

                

                     News, Updates and Events

 

Superintendent of Public Health Circular - Advance Therapy medicinal product as defined in regulation (EC) No 1394/2007 and used in Malta. Read More [19.01.2012]

Press Release: The Medicines Authority recognised for People Management and Employee Engagement. Read more [12.12.2011

EC Consultation: European Commission Public consultation paper on the review of Regulation (EC) 1234/2008 to the handling of variations to purely national marketing authorisations.  CircularPaper [11.10.2011]

Circular and Publication: Information Leaflet on Reference, Generic and Falsified Medicines published by the Medicines Authority. Circular l  Leaflet MT l Leaflet EN l Posters [30.09.2011]

Consultation (Including Seminar Presentations): Regulation for Medicines You can Trust.  Seminar Invitation l Directive 2010/84/EU l Q&A on Pharmacovigilance Directive l  Information Session Presentation on Directive 2010/84/EU Directive 2011/62/EU l Q&A on Falsified Medicines Directive  Information Session Presentation on Directive 2011/62/EU [11.10.2011]

EC Consultation: Public Consultation on implementing measures for pharmacovigilance. Circular. Paper. [16.09.2011]

Press Releases: Superintendence of Public Health notice on the product 'Dr Numb'. Read more [05.09.2011]

Circular: Medicines Authority launches SMS Notification Service. Circular. Subscribe. [12.08.2011]

Circular: IMI Education and Training Programmes and 4th Call for Proposals. Circular. Flyer. [25.05.2011]

Consultation: Concept paper on the revision of the 'Clinical Trials Directive' 2001/20/EC. Covering Letter Concept Paper [10.05.2011

Conference: Consumer Protection Read More [21.04.2011]

Invitation: Innovative Medicines Initiative Stakeholder Forum Read more [12.04.2011]

Conference: The Regulatory Authorities - their role in protecting consumers.  Read More [01.04.2011]

Training session: Herbal Medicinal Products. Read More [01.04.2011]

Training session: Counterfeit Medicines. Read More [01.04.2011]

Training session: Regulation of Supply Chain of Medicinal Products. Read more [07.03.2011]

Publication:  Medicines Authority publishes Annual Report for 2010. Read More [03.03.2011]

Training Session: Supporting the National Pharmacovigilance System in 2011.    Read More [22.02.2011]

Customer Care: Complaints procedure on the website Read More [09.02.2011]

Training Session: Information on Medicinal Products.  Read More [04.02.2011]

Publication:  Medicines Authority publishes Rapport ta' Ħidma għas-Sena 2010. Read More [03.02.2011]

Circular: Medicines Authority launches stakeholder survey. Circular Participate.  [02.02.2011]

DCP with Malta as RMS:  Some slots have become available for procedures in Q3 and Q4 of 2011. Read more [02.02.2011]

Training Session: Marketing Authorisation Assessments.  Read More [01.02.2011]

Continuing Professional Development: The Medicines Authority collaborates with the Malta College of Pharmacy Practice to deliver training opportunities. Read more [26.01.2011]

Consultation Meeting:  Variations Legal Notice. Presentation.  Draft Legislation [21.01.2011]

Press Release: The Medicines Authority launches an information campaign on medicines. Press Release English Press Release Maltese [11.01.2011]

Press Release: The Medicines Authority receives three awards for good practice and quality initiatives in people management. Read more [13.12.2010]

Press Release: Seven major medical areas boosted through innovative European public private partnership Read more [07.12.2010]

Follow the Medicines Authority on Facebook - Find out more [01.12.2010]

Join the Know Your Medicines Facebook group - Join [01.12.2010]

Updated Function for the Malta Medicines List - Read more [30.11.2010]

Launch of Knowyourmedicines.gov.mt website - Read more [22.10.20210]

Innovative Medicines Initiative - Third Call for Proposals and Open Info Day Read more [13.10.2010]

Herbal Registration Deadline Read more [13.08.2010]

Draft Paper for Consultation: European Heads of Medicines Agencies (HMAStrategy Paper II Read more [20.07.2010]

Information regarding the US FDA recall of McNeil Consumer Healthcare Products Read more [07.05.2010]

Information Session (Herbal Medicinal Products) Read more [04.05.2010] - Presentations uploaded

Information session (Community Pharmacy Practice) Read more [04.05.2010] - Presentations uploaded

Medicines Authority organises training with its UK counterpart.  Read more [19.01.2010]

Update on the requirement for national renewals. Read more [13.01.2010]

Update on variations legislation. Read more [01.12.2009]

The Medicines Authority awarded the FHRD HR Award. Read more [01.12.2009]

Innovative Medicines Initiative - Second Call for Proposals Read more [19.10.2009]

Medicines Authority Circular No P06/2009  Re: Use of over-the-counter cough and cold medicines in children - Update - 02.03.2009

Medicines Authority Circular No P03/2009 Re: The EMEA recommends suspension of the marketing authorisation of Raptiva (efalizumab) - 19.02.2009

Medicines Authority Circular No P11/2008 Re: The EMEA recommends the suspension of the marketing authorisation of Acomplia - 23.10.2008

Information on fee payments

Twinning Light 2008

Update on Heparin Products

Medicines Authority Circular P04/08 - Over-the-counter cough and cold medicines for children

Further capacity building at the Medicines Authority

Expression of interest for expertise to support the Medicines Authority on assessment and pharmaceutical activities related to medicinal products for human use.

Persons to carry out Maltese Translation Checks

Implementation of article 126(a) of Directive 2004/27/EC Medicines (Marketing Authorisation) Regulations - More information

Package Leaflets (PLs) and Summary of Product Characteristics (SPCs) of authorised products are now available . Click here

Medicines Authority Circular No I01/2005: Revocation of Wholesale Dealer's Licence of John Meli & Co - 21/11/2005

Medicines Authority Circular P18-2005 RE: Post-licensing requirements with respect to submission of Periodic Safety Update Reports (PSURs) for products licensed through the PMA-MA procedure.

Bank Details for the Payment of Fees

Medicines Authority Circular No P17/2005: Post-licensing requirements with respect to submission of recently approved variations or ongoing variations which are not reflected in the dossier submitted for a Marketing Authorisation  get file in pdf format

 10 September 2004. Applications for Registration of Qualified Persons (QPs).  get file in pdf format

The list of Products given a Marketing Authorisation via the Centralised Procedure can be found on the EMEA website.

Pulmicort 200 microgram/dose pMDI (Class II Medicines Recall)

   

 

 

Marketing Authorisations | Parallel Importation | Clinical Trials | Herbal Medicinal Products | Homeopathic Products | Borderline Classification Committee | Advertising | Scientific Advice | Publications | Disclaimer | Copyright | Privacy Policy | Contact UsFeedback Form | Search

The content has been collated by staff of the Medicines Authority
Please if you require other information that is not on these pages. We will do our best to help you.